Search Within

Nicholas Vander Els

  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (7)
  2. Division of Subspecialty Medicine (7)
  3. Pulmonary (7)
  4. Solid Tumor Oncology Division (7)
  5. Epidemiology and Biostatistics (4)
  6. Biostatistics Service (3)

More Groups

People
  1. Zhigang Zhang (3)
  2. Abraham Wu (2)
  3. Alexander Geyer (2)
  4. Andreas Rimner (2)
  5. Annemarie Shepherd (2)
  6. Charles Rudin (2)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2016 (1)
  4. 2010 (1)
  5. 2006 (1)
  6. 2003 (1)

More Years

Publications
  1. Annals of Oncology (1)
  2. Blood (1)
  3. Cancer Investigation (1)
  4. Clinical Cancer Research (1)
  5. International Journal of Radiation Oncology, Biology, Physics (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (1)
  2. American Society of Clinical Oncology (1)
  3. American Society of Hematology (1)
  4. Elsevier Inc. (1)
  5. Elsevier Science, Inc. (1)
  6. Informa Healthcare (1)

More Publishers

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase 2 placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis
    Journal Article

    Rimner, A.; Moore, Z. R.; Lobaugh, S.; Geyer, A.; Gelblum, D. Y.; Abdulnour, R. E. E.; Shepherd, A. F.; Shaverdian, N.; Wu, A. J.; Cuaron, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Randomized, phase II, placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis
    Meeting Abstract

    Moore, Z. R.; Rimner, A.; Lobaugh, S.; Geyer, A.; Gelblum, D. Y.; Shepherd, A. F.; Shaverdian, N.; Wu, A. J.; Chaft, J. E.; Zauderer, M. G.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Yahalom, J.; Schöder, H.; Barr, P. M.; Caron, P.; Chiu, A.; Constine, L. S.; Drullinsky, P.; Friedberg, J. W.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Farletuzumab, a humanized monoclonal antibody against folate receptor α, in epithelial ovarian cancer: A phase I study
    Journal Article

    Konner, J. A.; Bell-Mcguinn, K. M.; Sabbatini, P.; Hensley, M. L.; Tew, W. P.; Pandit-Taskar, N.; Vander Els, N.; Phillips, M. D.; Schweizer, C.; Weil, S. C.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • Phase I study of MORAb-003, a humanized anti-folate receptor-alpha monoclonal antibody, in platinum resistant ovarian cancer
    Meeting Abstract

    Konner, J. A.; Ahmed, S.; Gerst, S.; Els, N. V.; Pezzulli, S.; Sabbatini, P.; Hensley, M.; Dupont, J.; Tew, W.; Aghajanian, C.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Arterial desaturation syndrome following pleurodesis with talc slurry: Incidence, clinical features, and outcome
    Journal Article

    Bondoc, A. Y.; Bach, P. B.; Sklarin, N. T.; Vander Els, N. J.
    Cancer Investigation (2003)

    Fulltext@MSK | Save
  • Fatal respiratory failure associated with treatment of prostate cancer using docetaxel and estramustine
    Journal Article

    Morris, M. J.; Santamauro, J.; Shia, J.; Schwartz, L.; Vander Els, N.; Kelly, K.; Scher, H.
    Urology (2002)

    Fulltext@MSK | Save